Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Statin use and clinical outcomes in patients with COVID-19: An updated systematic review and meta-analysis
Rimesh Pal, Mainak Banerjee, Urmila Yadav, et al.
Postgraduate Medical Journal (2021) Vol. 98, Iss. 1159, pp. 354-359
Open Access | Times Cited: 54

Showing 26-50 of 54 citing articles:

Effect of common maintenance drugs on the risk and severity of COVID-19 in elderly patients
Kin Wah Fung, Seo Hyon Baik, Fitsum Baye, et al.
PLoS ONE (2022) Vol. 17, Iss. 4, pp. e0266922-e0266922
Open Access | Times Cited: 10
All-cause mortality in COVID-19 patients receiving statin therapy: analysis of veterans affairs database cohort study
Ali El-Solh, Yolanda Lawson, Daniel A. El-Solh
Internal and Emergency Medicine (2021) Vol. 17, Iss. 3, pp. 685-694
Open Access | Times Cited: 12
Could Statin Therapy Be Useful in Patients With Coronavirus Disease 2019 (COVID-19)?
José D. Torres‐Peña, Niki Katsiki, Pablo Pérez-Martı́nez
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 12
Anesthesia and intensive care for patients with COVID-19. Russian Federation of anesthesiologists and reanimatologists guidelines
И. Б. Заболотских, М. Yu. Кirov, К. М. Лебединский, et al.
Annals of critical care (2022), Iss. 1, pp. 5-140
Open Access | Times Cited: 9
Finding answers in lipid profile in COVID-19 patients
Miguel Sampedro‐Núñez, N. Aguirre-Moreno, Lucio Garcia-Fraile Fraile, et al.
Endocrine (2021) Vol. 74, Iss. 3, pp. 443-454
Open Access | Times Cited: 11
Associations of statin use with 30-day adverse outcomes among 4 801 406 US Veterans with and without SARS-CoV-2: an observational cohort study
Pandora L. Wander, Elliott Lowy, Lauren A. Beste, et al.
BMJ Open (2022) Vol. 12, Iss. 3, pp. e058363-e058363
Open Access | Times Cited: 8
In Vitro Evidence of Statins’ Protective Role against COVID-19 Hallmarks
Donatella Fiore, Maria Proto, Silvia Franceschelli, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2123-2123
Open Access | Times Cited: 8
Outpatient atorvastatin use and severe COVID‐19 outcomes: A population‐based study
Irene Visos‐Varela, Maruxa Zapata‐Cachafeiro, Samuel Pintos‐Rodríguez, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 7
Open Access | Times Cited: 4
Assessing medication use patterns by clinical outcomes severity among inpatients with COVID-19: A retrospective drug utilization study
Renato Ferreira‐da‐Silva, Priscila A. Maranhão, Cláudia Camila Dias, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116242-116242
Open Access | Times Cited: 1
Resurgence of COVID-19 and diabetes in India
Rimesh Pal, Sanjay Kumar Bhadada, Anoop Misra
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2021) Vol. 15, Iss. 3, pp. 1037-1038
Open Access | Times Cited: 9
Association of antecedent statin use on 30-day, 60-day and 90-day mortality among Mississippi Medicaid beneficiaries diagnosed with COVID-19
Yiran Rong, Swarnali Goswami, O Eriakha, et al.
BMJ Open (2023) Vol. 13, Iss. 11, pp. e076195-e076195
Open Access | Times Cited: 3
A metabolic blueprint of COVID-19 and long-term vaccine efficacy
Engin Berber, Deepak Sumbria, Serkan Kökkaya
Drug Metabolism and Personalized Therapy (2022) Vol. 38, Iss. 1, pp. 15-29
Open Access | Times Cited: 5
Statins Use in Patients with Cardiovascular Diseases and COVID-19 Outcomes: An Italian Population-Based Cohort Study
Ippazio Cosimo Antonazzo, Carla Fornari, Davide Rozza, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 24, pp. 7492-7492
Open Access | Times Cited: 5

Alireza Kamali, Masoumeh Sofian, Behnam Mahmodiyeh, et al.
Journal of Medicinal and Chemical Sciences (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 1
O cuidado farmacêutico na redução do impacto da pandemia de COVID-19 na saúde cardiovascular de pacientes hipertensos e diabéticos
Nathália Castilho Roque, Vitor Franco Machado, Maurílio de Souza Cazarim
Medicina (Ribeirão Preto) (2023) Vol. 56, Iss. 4
Open Access | Times Cited: 1
Statin use and clinical outcomes in hospitalized COVID-19 patients
Khalid Saud Alshaalan, Rahaf F. Alkahtani, Renad Althobaiti, et al.
Saudi Medical Journal (2024) Vol. 45, Iss. 2, pp. 171-178
Open Access
Effect Of Long-Term Use Of Antithrombotics And Statins On COVID-19 Mortality And Clinical Severity
Emrah Aksakal, Selim Aydemir, Faruk Aydınyılmaz, et al.
Recent trends in pharmacology. (2024), pp. 67-74
Open Access
Statins for the treatment of COVID-19 patients: an updated meta-analysis of randomized controlled trials
Fatemeh Movahed, Ehsan Heidari, Masoud Dehbozorgi, et al.
Deleted Journal (2024) Vol. 1, Iss. 1
Open Access
Atorvastatin and telmisartan do not reduce nasopharyngeal carriage of SARS-CoV-2 in mild or moderate COVID-19 in a phase IIb randomized controlled trial
Fabrice Bonnet, Adama Doumbia, Vanessa Machault, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Klotho Deficiency in Severe COVID-19: A Unifying Hypothesis
Natalia Campos‐Obando, M. Carola Zillikens, Román F. Macaya
COVID (2024) Vol. 4, Iss. 12, pp. 1833-1850
Open Access
Low LDL cholesterol and risk of bacterial and viral infections – observational and Mendelian randomisation studies
Marianne Benn, Frida Emanuelsson, Anne Tybjærg-Hansen, et al.
European Heart Journal Open (2024) Vol. 5, Iss. 1
Open Access
The impact of atherosclerotic cardiovascular disease, dyslipidaemia and lipid lowering therapy on Coronavirus disease 2019 outcomes: an examination of the available evidence
Safwaan Adam, Jan Hoong Ho, Bilal Bashir, et al.
Current Opinion in Lipidology (2021) Vol. 32, Iss. 4, pp. 231-243
Closed Access | Times Cited: 2
Statins and COVID-19 (Mechanism of Action, Effect on Prognosis)
Joanna Lewek, Stanisław Surma, Maciej Banach
Contemporary cardiology (2022), pp. 285-302
Closed Access | Times Cited: 1
Protective effects of statins on COVID-19 risk, severity and fatal outcome – a nationwide Swedish cohort study
Ailiana Santosa, Stefan Franzén, Jonatan Nåtman, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
Role of Statin and Clinical Outcomes in COVID-19 Patients: A Protocol for Systematic Review and Meta-analysis of Randomized Controlled Trials
Amit Kumar, Sharmili Sinha, Jay Prakash, et al.
(2023) Vol. 2, Iss. 1, pp. 38-41
Open Access

Scroll to top